Chimeric Primers for Parallel Gene Expression Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current microarray-based gene expression analysis is limited by high costs and the need for large RNA quantities, making it impractical for analyzing multiple samples, and existing screening methods fail to effectively assess the impact of compounds on complex diseases like cancer due to their focus on single genes or broad phenotypic responses.
Innovation Solution
The use of novel compositions and methods that combine microarray technology with RNA sample amplification techniques, including barcode sequences, to enable the parallel analysis of multiple RNA samples using gene-specific and universal primers, allowing for the reuse of generic arrays and reducing the need for global labeling, thereby lowering costs and increasing analytical efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current microarray sample labeling methods are used, then gene expression analysis can be performed, but the cost is high (e.g., $100 per sample) and large quantities of RNA are required
Solution Approach 1:
The patent segments the global amplification process into gene-specific amplification using chimeric primers. Each primer pair is designed to amplify specific target genes, allowing selective enrichment of desired transcripts rather than amplifying all RNA in the sample. This segmentation enables analysis of small RNA quantities for specific genes without requiring large total RNA amounts.
Solution Approach 2:
The chimeric primers incorporate gene-specific sequences that provide local amplification capability. The 5' end of each primer contains a universal sequence for amplification while the 3' end contains gene-specific binding sites. This local quality allows the system to amplify only the intended target genes from minimal RNA input, resolving the contradiction between analysis capability and RNA quantity requirements.
2Quantity of substance
If global amplification schemes are used to compensate for small sample size, then RNA quantity limitation is addressed, but additional sample handling steps and expense are added
Solution Approach 1:
The patent merges the amplification and labeling functions into a single step. The chimeric primers simultaneously perform template annealing, primer binding, and amplification initiation in one reaction mixture, eliminating separate amplification and labeling steps required by conventional methods. This merging reduces sample handling complexity while maintaining the ability to work with small RNA quantities.
Solution Approach 2:
The universal sequence at the 5' end of the chimeric primers provides multi-functionality: it enables amplification of the target gene while also serving as a binding site for fluorescently labeled probes in the same reaction. This universal design integrates multiple functions (amplification and detection) into a single step, reducing the number of handling operations required.
3Adaptability or versatility
If global amplification is used, then all RNA transcripts are amplified, but each individual gene is represented in relatively low ratio relative to all remaining amplified transcripts
Solution Approach 1:
The patent extracts and enriches specific target genes from the complex RNA mixture using gene-specific chimeric primers. By designing primers that selectively bind to and amplify only the intended target sequences, the method extracts the signal of interest from the background noise of other transcripts. This extraction approach dramatically improves the representation ratio of target genes in the final amplified product.
Solution Approach 2:
Instead of amplifying all transcripts globally, the method applies partial amplification to only the selected target genes. The chimeric primers provide excessive specificity, amplifying only the desired sequences while leaving other transcripts unamplified. This partial action concentrates the amplified material into the target gene population, improving measurement precision for those genes.
4Adaptability or versatility
If phenotypic screens are used to capture gross cellular changes, then broad cellular responses are observed, but the ability to differentiate multiple pathways is lost
Solution Approach 1:
The patent segments the broad phenotypic response into specific gene-level measurements. By using gene-specific chimeric primers to amplify and detect individual transcripts, the system can identify which specific genes are affected by a treatment. This segmentation allows differentiation of multiple pathways (e.g., apoptosis, necrosis, autophagy) by measuring the expression status of specific pathway-related genes, resolving the contradiction between broad capture and precise differentiation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables cost-effective, high-throughput gene expression profiling of multiple samples with reduced RNA requirements, allowing for the simultaneous analysis of multiple genes and compounds, providing a more comprehensive understanding of gene interactions and disease mechanisms.
Implementation Method 1
The 3' end of each primer is complementary to a sequence in a target RNA while the 5' end of each primer is a universal sequence
Implementation Method 2
amplification of a selected set of RNA transcripts by a polymerase chain reaction (PCR) using the chimeric primers
Implementation Method 3
A fluorescent label is coupled to the universal primer sequence
Data Source
AI summary
The invention provides novel compositions and methods for the analysis of gene expression (e.g., expression profiling) using microarray-based technology. In some embodiments of the invention, the novel methods use gene-specific as well as universal amplification primers during sample preparation, and the methods permit the simultaneous analysis of multiple samples on the same microarray. Furthermore, some embodiments of the invention incorporate barcode sequences into the amplified products, thereby permitting the use of generic arrays and generic labeled probes.